What is OS Therapies's warrant exercise price decrease?

OS Therapies (OSTX) reported warrant exercise price decrease of $1.40 in Q1 2026.

What does warrant exercise price decrease mean?

A modification to the terms of outstanding warrants that lowers the price at which holders can purchase common stock. This is often used to incentivize exercise or as a response to market conditions, signaling potential future dilution for existing shareholders.

OS Therapies OSTX Warrant Exercise Price Decrease

Warrant Exercise Price Decrease at other companies

General Purpose Acquisition Corp. GPAC

$115.00+900%

Jaguar Uranium JAGU

$2.86—

Insight Digital Partners II DYOR

60%—

Apollo Global ManagementAPO

$82.56-0.2%

Envoy MedicalCOCH

$2.95M+114%

Cineverse Corp.CNVS

$1.46M—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:WarrantExercisePriceDecrease.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's warrant exercise price decrease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's warrant exercise price decrease?: OS Therapies (OSTX) reported warrant exercise price decrease of $1.40 in Q1 2026.
What does warrant exercise price decrease mean?: A modification to the terms of outstanding warrants that lowers the price at which holders can purchase common stock. This is often used to incentivize exercise or as a response to market conditions, signaling potential future dilution for existing shareholders.